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1. Introduction 
Myocarditis is a potentially life-threatening heart disease affecting both children and adults 
which presents with a broad spectrum of clinical manifestations. Symptoms range from 
asymptomatic infection to a fulminant course that rapidly progresses to dilated 
cardiomyopathy (DCM) and heart failure. Viral infection of the heart is a major cause of 
acute myocarditis, leading to myocardial inflammation and tissue damage. Cellular 
infiltration in acute viral myocarditis may be caused by direct cytopathic effects of the virus, 
pathologic responses to persistent viral replication as well as autoimmunity triggered by the 
virus (Liu and Mason, 2001; Bowles and Vallejo, 2003; Linde et al., 2007; Rose et al., 2009; 
Rutschow et al., 2010). The cardiovirulence of the viral agent, together with the host´s 
genetic susceptibility and the variability in the innate and acquired immune system, appear 
to determine the extent of the inflammatory reaction, thereby predicting clinical outcome 
(Kindermann et al., 2008).  
Recently, meaningful advances have been made in our understanding of cellular 
mechanisms that are aimed to suppress viral propagation in inflammatory heart disease. In 
the first line of defense against viral replication, the host´s innate immune system is 
activated by unspecific, albeit effective interactions of cellular receptors with distinct 
pathogen-derived ligands. A variety of pattern-recognition receptors have been shown to be 
implicated in the detection of invading microbial agents (Kawai and Akira, 2010; Takeuchi 
and Akira, 2010). Upon viral infection of the heart, different signal pathways initiate an 
inflammatory response and orchestrate the concerted anti-viral defense machinery in a 
complex manner. Toll-like and RIG-I-like receptors are essential for the recognition of 
pathogen-associated molecular patterns and their activation induces intracellular signalling 
pathways which lead to the production of pro-inflammatory cytokines, chemokines, and 
interferons (Bowles and Vallejo, 2003; Fairweather et al., 2005; Triantafilou et al., 2005; 
Frantz et al., 2007; Linde et al., 2007; Yajima and Knowlton, 2009; Kawai and Akira, 2010; 
Takeuchi and Akira, 2010; Yamamoto and Takeda, 2010; Zhu and Mohan, 2010). Vice verse, 
interferons appear to induce the expression of a subset of toll-like receptors (Khoo et al., 
2011). Type I interferons execute anti-viral responses by modulating cell growth, 
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establishing an anti-viral state and influencing the activation of various immune cells. These 
potent anti-viral cytokines are best known for their role as innate immune mediators 
(Yajima and Knowlton, 2009). In the course of viral myocarditis, apoptotic signalling 
pathways are activated and modulate disease pathogenesis. However, cardiotropic viruses 
have evolved a battery of highly specific strategies to circumvent this innate protective 
response of the host and successfully replicate in cardiomyocytes (Versteeg and García-
Sastre, 2010). Viral factors with or without homology to host proteins specifically target key 
components of the anti-viral defense machinery, some of which are transcription factors 
involved in establishing an anti-viral state.  
In the present review we focus on the contribution of pattern-recognition receptors engaged 
in the early response cascade against cardiotropic viruses. In particular, we report on 
different signal transduction pathways emerging from membrane-associated and cytosolic 
receptors that inhibit viral dissemination and, furthermore, give a brief overview of the 
various adaptor molecules involved in these pathways. Not covered in this review are the 
diverse viral mechanisms for antagonizing the innate immune response and the precise 
cellular actions of cytokines in executing this anti-viral defense. Understanding the exact 
mechanisms by which viral components activate pattern-recognition receptors in the heart 
and modify gene expression profiles may help to improve novel therapeutic regimes for the 
treatment of viral myocarditis (Topkara et al., 2010).  
2. Clinical course of myocarditis 
Myocarditis is defined as a heterogeneous common disease pathway for myocardial 
inflammation resulting from a variety of infectious, immune and non-immune insults. The 
histopathologic hallmark of the disease is characterized by inflammatory infiltrates of the 
myocardium with concomitant necrosis or degeneration of adjacent cardiomyocytes in the 
absence of predominant ischemia. Despite this clear definition, the classification and 
diagnosis of myocarditis continue to present clinical problems. In recent years our 
understanding of the pathophysiology and natural clinical course of the disease has 
improved, probably because histological findings obtained from endomyocardial biopsies 
have routinely been combined with modern molecular biological and immunological tools 
in the detection of viral genomes persisting in the heart (Heidecker et al., 2011).  
From epidemiological studies, it is known that viruses are the most frequent cause of 
myocarditis in Europe and North America although in rare cases bacteria, protozoa, and 
even fungi have also been implicated as infectious agents (Ellis and Di Salvo, 2007). Among 
the more common cardiotropic viruses are enteroviruses including Coxsackie virus, 
adenoviruses, parvovirus B19, hepatitis C virus, and human immunodeficiency virus (Kühl 
et al., 2005; Magnani and Dec, 2006; Mahrholdt et al., 2006; Noutsias et al., 2009; Rose, 2009; 
Pankuweit and Maisch, 2010). Other non-infectious etiologies of myocardial inflammation 
include hypersensitivity reactions against drugs, unexplained toxic reactions, and 
immunological syndromes including Churg-Strauss syndrome, giant cell myocarditis, 
systemic lupus erythematosus, sarcoidosis, Wegener´s granulomatosis, and others (Magnani 
and Dec, 2006; Ellis and Di Salvo, 2007; Rose, 2009). Although infections with cardiotropic 
viruses are believed to be the most common cause of acute lymphocytic myocarditis, a large 
number of patients have no identifiable source of the illness (Liu and Mason, 2001; Rose, 
2009). Particularly, when the inflammatory process in the myocardium is moderate, the 
diagnosis frequently remains a challenge for clinicians. The diagnostic sensitivity for viral 
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myocarditis is comparably low, even when applying modern molecular biological 
techniques, probably because, due to sampling error, the diagnostic accuracy of 
endomyocardial biopsy remains a significant limitation (Magnani and Dec, 2006; Ellis and 
Di Salvo, 2007). The Dallas criteria, originally proposed in an effort to standardize the 
histopathologic diagnosis of myocarditis, have been shown to be of limited use for 
epidemiological investigations (Magnani and Dec, 2006; Ellis and Di Salvo, 2007). Thus, 
despite recent advances in the recognition of myocardial inflammation, the true incidence 
and prevalence of acute viral myocarditis is still unknown.  
The spectrum of clinical manifestations of viral myocarditis is extensive, ranging from 
asymptomatic infection to fever, myalgias, palpitations, exertional dyspnea, and 
hemodynamic collapse. Fulminant myocarditis may lead to systolic failure, malignant 
ventricular arrhythmias and sudden cardiac death (Baughman, 2005; Magnani and Dec, 
2006; Rose, 2009, Blauwet and Cooper, 2010). The cardiac symptoms may also be present in 
more chronic forms of DCM, therefore contributing much to the difficulties in establishing 
the correct diagnosis. The main reason for the clinical variability appears to lie in the 
characteristics of the viral agent, together with the host´s innate immune system and genetic 
susceptibility to infection. Given the diversity and insidious onset of clinical manifestations, 
endomyocardial biopsy in combination with other techniques such as immuno-
histochemistry, serological analyses, PCR and in situ hydridization remains the gold 
standard for the detection of virus-induced myocardial inflammation (Magnani and Dec, 
2006; Rose, 2009).  
Although, in severely affected individuals, fulminant viral myocarditis can lead to rapid 
progressive heart failure, the disease usually resolves spontaneously without persisting 
ventricular dysfunction (Baughman, 2005; Magnani and Dec, 2006; Rose, 2009, Blauwet and 
Cooper, 2010). Continuing cardiovascular symptoms in the absence of ventricular 
compromise may indicate that chronic persistent myocarditis has developed, which is 
characterized by the maintenance of lymphocytic infiltrates combined with foci of myocyte 
necrosis. Whereas it has been well-established that chronic active myocarditis can induce 
heart failure, there is still a controversy with respect to the causal relationship of 
asymptomatic viral infections for the pathogenesis of idiopathic DCM (Yajima and 
Knowlton, 2009). Several studies have suggested an association between viral persistence in 
the myocardium and the development of DCM. However, the etiologic significance of viral 
genomes detected in endomyocardial biopsies from DCM patients is currently unknown 
(Bock et al., 2010).  
3. Toll-like receptors in the inflamed heart  
Despite a wealth of information regarding the symptomatology and clinical course of the 
disease, the complex pathophysiological mechanisms underlying inflammatory heart 
disease are only partially understood. Lessons learned from transgenic mouse models have 
shed some light on the essential role of endogenous receptors and transcriptional regulators 
engaged in early anti-viral response. From clinical and animal studies we know that the 
host´s innate immune system acts as the first line of defense against viral replication in a 
wide array of pathogenic viruses. The innate immune system, which senses pathogen 
invasion and primes antigen-specific adaptive immunity, has long been considered to be 
only non-specific and somewhat simpler than that of the adaptive system. However, recent 
findings on pattern-recognition receptors and their downstream signalling pathways have 
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led to a reconsideration of the role of innate immunity now seen as a highly potent defense 
apparatus against microbial pathogens which works in close cooperation with adaptive 
immunity.  
Initial sensing of invading microorganisms by the innate immune system is mediated by 
pattern-recognition receptors (PRRs), which include toll-like receptors (TLRs), RIG-I-like-
receptors, NOD-like receptors, and C-type lectin receptors (Akira et al., 2006; Bauer et al., 
2009; Yajima and Knowlton, 2009; Kawai and Akira, 2010; Takeuchi and Akira, 2010). These 
four classes of germline-encoded PRR families are responsible for recognizing exogenous 
structures conserved among microbial species, which are called pathogen-associated 
molecular patterns (PAMPs). Currently, the paradigm of PRRs has changed, since it has 
been shown that PRRs also recognize endogenous molecules released from damaged cells, 
collectively termed damage-associated molecular patterns (DAMPs) (Piccinini and 
Midwood, 2010; Lamkanfi, 2011).  
Among the PRRs, toll-like receptors and C-type lectin receptors are transmembrane 
glycoproteins, whereas retinoic acid-inducible gene (RIG)-I-like receptors and NOD-like 
receptors function as cytosolic PRRs (Figure 1). Toll-like receptors were first discovered in 
Drosophila as evolutionary ancient molecules that function as receptors for endogenous 
ligands such as proteolytically cleaved Spätzle protein, but later were found to be present 
also in the mammalian system where they respond to microbial components as well as 
endogenous ligands including heat shock proteins HSP60, HSP70, and gp96 (Medzhitov et 
al., 1997; Ohashi et al., 2000; Vabulas et al., 2002; Vabulas et al., 2002b; Kim et al., 2009; Arnot 
et al., 2010). Toll-like receptors are expressed on macrophages, dendritic cells, endothelial 
cells, and interestingly also on cardiac myocytes (Boyd et al., 2006). Structurally, they are 
characterized by a highly variable amino-terminal region containing a leucine-rich repeat 
(LRR) ectodomain, followed by a hydrophobic transmembrane region and a cytoplasmic 
toll/interleukin 1 receptor (TIR) homology domain, which mediates interaction between 
TLRs and downstream signalling molecules (Choe et al., 2005; Bell et al., 2006; Jin et al., 
2007; Kang et al., 2009; Park et al., 2009). Ligand binding is mediated by the extracellular 
LRR ectodomain, which is composed of 19-25 tandem copies of the “xLxxLxLxx” motif (Jin 
and Lee, 2008). In humans, 10 members of the germline-encoded TLR family have been 
identified so far, TLR1-TLR9 being conserved in humans and mice. Due to a retroviral 
insertion, TLR10 is not functional in mice and the murine TLRs 11-13 are not present in 
humans (O'Neill, 2008; Kawai and Akira, 2010).  
Ligand binding of PAMPs by TLRs occurs at the plasma membrane (TLR1, TLR2, TLR4-6) as 
well as in endolysosomal compartments and the endoplasmic reticulum (TLR3, TLR7-9) 
(Frantz et al., 2007. Kawai and Akira, 2010; Takeuchi and Akira, 2010; Yamamoto and 
Takeda, 2010). The difference in the downstream signalling cascades activated can be partly 
explained by the individual TLR molecule, which recognizes a specific subset of PAMPs and 
recruits different TIR domain-containing adaptors to the receptor. Ligands for TLRs include 
a broad range of various microbial components, such as bacterial lipoprotein moieties 
(TLR1-2, TLR6), lipopolysaccharide (TLR4), and flagellin protein (TLR5). Toll-like receptor 3, 
the first TLR family member to be implicated in the recognition of viral nucleic acids, binds 
to double-stranded RNA (dsRNA) molecules, which are produced as intermediates during 
the replication cycle of many viruses (Alexopoulou et al., 2001). TLR7 and TLR8 receptors 
recognize single-stranded RNA (ssRNA) and are expressed in a variety of immune cells, 
including dendritic cells, lymphocytes, monocytes, and NK cells (Bauer et al., 2008). 
Triantafilou and co-workers reported that inflammatory responses in human myocarditis 
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Fig. 1. Signalling pathways engaged in the detection of highly conserved, relatively 
invariant structural motifs of pathogens. Depicted are different pathways for the recognition 
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of microbial infection including toll-like receptor (TLR)-mediated MyD88-dependent and 
TRIF-dependent pathways as well as cytosolic sensors for foreign nucleic acid sequences 
(STING, RIG-I, and MDA5). For details on key receptors, their signalling adaptors and 
downstream mediators see text. Abbreviations: IKK; IB kinase, IRAK; IL1-receptor-
associated kinase, IRF; interferon-regulatory factor, MDA5; melanoma differentiation-
associated gene 5, MyD88; myeloid differentiation primary response gene 88, NEMO; NF-B 
essential modulator, NF-B; nuclear factor-B, RIG-I; retinoic acid-inducible gene-I, STING; 
stimulator of interferon genes, TAK1; transforming growth factor--activated kinase 1, 
TBK1; TANK-binding kinase 1, TIRAP; toll-interleukin 1 receptor (TIR) domain-containing 
adaptor protein, TLR; toll-like receptor, TRAF; tumour necrosis factor receptor-associated 
factor, TRIF; TIR-domain-containing adaptor protein inducing interferon-ǃ (also known as 
TICAM), TRAM; TRIF-related adaptor molecule. 
induced by Coxsackie virus B3 (CVB3) are mediated through TLR8 and to a lesser extent 
through TLR7 (Triantafilou et al., 2005). Elevated expression levels of TLR8 have been 
associated with heart failure and adverse clinical outcome in patients with enterovirus-
associated dilated cardiomyopathy (Satoh et al., 2007). Toll-like receptor 9 functions as a 
sensor for unmethylated cytosine-phosphate-guanine (CpG) sequences in bacterial and viral 
DNA, which are rarely found in vertebrates (Barton et al., 2006; Guggemoos et al., 2008). 
Riad and colleagues demonstrated that, in the acute phase of CVB3-induced myocarditis, 
TLR9 knockout mice displayed improved LV function associated with reduced cardiac 
inflammation as compared to CVB3-infected wild-type mice. The cardioprotective effects 
due to TLR9 deficiency were associated with suppression of the TLR9 downstream pathway 
as indexed by reduced cardiac levels of the adapter protein MyD88 and the 
proinflammatory cytokine TNF-ǂ (Riad et al., 2010). 
In non-infected cells, TLR3 and TLR7-9 reside in the endoplasmic reticulum, whereas after 
uncoating and exposure to viral nucleic acids they traffic to the endosomal compartments, 
where they finally trigger a signal cascade resulting in the activation of the transcription 
factor NF-B. The subcellular localization of the various TLR family members appears to be 
tightly regulated, probably because this avoids unbalanced activation to self-DNA in the 
absence of viral encounter. The diverse distributions of individual TLRs allow for the 
surveillance of different intracellular compartments, as viral entry usually occurs by 
receptor-mediated endocytosis and endosomal fusion or by direct fusion with the plasma 
membrane (Barton et al., 2006; Barton and Kagan, 2009). 
Structural studies have revealed that the hydrophobic ligands of TLR1, TLR2, and TLR4 
interact with internal protein pockets on the ectodomain, while hydrophilic dsRNA binds to 
the solvent-exposed surface of TLR3. Binding to cognate ligands induces homodimerization 
of the TLR ectodomains, whereas TLR2 forms heterodimers with TLR1 or TLR6 which 
interact with triacyl- and diacyl lipoproteins, respectively (Jin et al., 2007; Kang et al., 2009; 
Kawai and Akira, 2010). The membrane-adjacent carboxy-termini of the extracellular 
domains then converge and probably facilitate dimer formation of the cytoplasmic TIR 
domains to activate intracellular signalling.  
Upon stimulation, the dimeric TLR molecules, except for TLR3, recruit a cytoplasmic 
adaptor called MyD88 (myeloid differentiation primary response gene 88), which is 
composed of a death domain (DD) in addition to a TIR domain (Muzio et al., 1997; Frantz et 
al., 2007; Kawai and Akira, 2010). CpG-DNA activates the TLR signaling pathway via 
MyD88 and TRAF6 (tumour necrosis factor receptor-associated factor 6), leading to 
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activation of kinases of the IB kinase complex (Häcker et al., 2000). When infected with the 
spirochete Borrelia burgdorferi, mice deficient in MyD88 expression develop myocarditis and 
arthritis similar to the disease in wild-type mice (Liu et al., 2004). However, the pathogen 
burden was much higher in MyD88-/- mice than in wild-type mice, probably because 
degradation of the bacteria was critically impaired.  
In response to stimulation with dsRNA, TLR3 recruits another adaptor molecule referred to 
as TRIF (TIR domain-containing adaptor protein inducing interferon-ǃ, also known as 
TICAM), which associates with TRAF6 and RIP1 (receptor interacting protein 1) (Yamamoto 
et al., 2003). TRIF plays a critical role in MyD88-independent TLR3 signalling via TRAF6 and 
TANK-binding kinase (TBK)-1, leading to the activation of two distinct transcription factors, 
NF-B and interferon-regulatory factor 3 (Sato et al., 2003). Hardarson and colleagues 
reported that TLR3 is an essential component of the innate stress response in 
encephalomyocarditis virus (EMCV)-induced cardiac injury (Hardarson et al., 2007). Mice 
lacking TLR3 expression were more susceptible to EMCV infection and had a significantly 
higher viral load in the heart, but lesser inflammatory changes of the myocardium as 
compared to control mice. TLR3-deficient mice had impaired proinflammatory cytokine and 
chemokine production in the heart, while expression of interferon- was not impaired 
(Hardarson et al., 2007). 
Satoh and colleagues reported that in 44 patients with myocarditis increased expression of 
TLR4 was associated with replication of enteroviral RNA and that these RNA levels were 
related to cardiac dysfunction (Satoh et al., 2003). In TLR4 signalling, the ligand-bound 
receptor utilizes MyD88 and TIRAP (toll-interleukin 1 receptor (TIR) domain-containing 
adaptor protein) for MyD88-dependent as well as TRIF and TRAM (TRIF-related adaptor 
molecule) for MyD88-independent pathways (Yamamoto et al., 2003b; Fitzgerald et al., 
2003). The adaptor protein TRAM is required for activation of TRIF and recently a splice 
variant of TRAM called TAG (TRAM adaptor with GOLD domain) has been identified that 
acts as a negative regulator of TRIF-dependent signalling (Palsson-McDermott et al., 2009). 
TLR1, TLR2, TLR4, and TLR6 signalling requires, in addition, TIRAP which is important for 
bridging between the cytoplasmic TLR tail and MyD88 (Fitzgerald et al., 2001). Recently, it 
was shown that infection with Coxsackie virus group B serotype 3 (CVB3) resulted in 
cardiac remodelling, severe heart failure, and high mortality in TRIF-deficient mice, while 
wild-type mice showed only mild myocarditis and normal survival postinfection (Riad et 
al., 2011). Furthermore, virus control was markedly reduced in mice lacking TRIF expression 
and, interestingly, TRIF-deficient myocytes displayed a TLR4-dependent suppression of 
interferon-ǃ. These findings suggest that TRIF confers cardioprotection against CVB3 
infection.  
The recruitment of these adaptors triggers a cascade of signalling events, which leads to the 
activation of the transcription factors NF-B and interferon-regulatory factors (IRFs). These 
transcription factors ultimately induce the expression of various inflammatory cytokines, 
which execute important functions in anti-viral defence. The first step in the synthesis of 
cytokines leads to the activation of interleukin 1 receptor-associated kinase 4 (IRAK4), which 
functions as a serine/threonine kinase with an aminoterminal death domain (DD) (Suzuki et 
al., 2002; Suzuki et al., 2002b). Subsequently, IRAK1 and IRAK2 are phosphorylated by 
IRAK4 and, after dissociation of MyD88, a complex with TRAF3 and TRAF6 is formed 
(Kawagoe et al., 2007; Kawagoe et al., 2008; Lin et al., 2010). TRAF6 acts as an E3 ligase in 
conjugation with the E2 ubiquitin-conjugating enzymes Ubc13 and Uev1A and catalyzes the 
formation of a lysine63-linked polyubiquitin chain on target proteins, including TRAF6 
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itself, IRAK, and the NF-B essential modulator (NEMO) (Deng et al., 2000). Transforming 
growth factor--activated kinase 1 (TAK1) is recruited and ubiquitinylated by TRAF6 (Wang 
et al., 2001). Subsequently, the IKK complex composed of IKK, IKK and NEMO is formed 
which phosphorylates inhibitor of NF-B (IB) kinase-ß (IKK). The activated IKK complex 
then induces phosphorylation and subsequent degradation of IB by the proteasome. Upon 
degradation of IB, the freed NF-B is no longer sequestered in the cytosol, but translocates 
into the nucleus, where it drives the expression of cytokine genes. Simultaneously, TAK1 
activates the mitogen-activated protein kinase (MAPK) cascade leading to the activation of 
the transcription factor AP-1, which also targets gene expression of cytokine genes (Wang et 
al., 2001). 
4. Cytosolic sensors for recognizing foreign nucleic acids 
Members of the cytosolic RIG-I-like receptor (RLR) family act as cytosolic sensors for 
genomic RNA of dsRNA viruses and dsRNA intermediates that are generated during 
replication of ssRNA viruses (Yoneyama et al., 2004; Kato et al., 2005; Bowzard et al., 2009; 
Ranjan et al., 2009). Retinoic acid-induced protein I is composed of two amino-terminal 
caspase activation and recruitment domains (CARDs), a central DEAD box helicase/ATPase 
domain, and a carboxy-terminal regulatory domain (Yoneyama et al., 2004). The latter 
domain plays a critical role in the specific recognition of dsRNA and 5′-triphosphorylated 
ssRNA. Other members of the RIG-I family include MDA5 (melanoma differentiation-
associated gene 5) and LGP2 (laboratory of genetics and physiology 2). RIG-I and MDA5 
distinguish between different RNA viruses and contribute to the host´s anti-viral response 
through recognition of either 5′-triphosphorylated and uncapped ssRNA or dsRNA, species 
not found among endogenous self-RNA (Kato et al., 2006). Transgenic mice, deficient in 
RIG-I or MDA5 expression, are highly susceptible to infection with RNA viruses compared 
to control mice (Kato et al., 2006). The RIG-I homolog LGP2, which lacks the amino-terminal 
CARDs, potentiates viral RNA recognition by RIG-I and MDA5 through its ATPase domain 
and has been found to be essential for type I interferon production in response to 
picornaviridae infection (Satoh et al., 2010). Recently, it has been shown that also DNA-
dependent RNA polymerase III is pivotal in sensing viral DNA in the cytoplasm (Ablasser 
et al., 2009; Chiu et al, 2009). AT-rich dsDNA can serve as a template for RNA polymerase 
III, which is transcribed enzymatically into dsRNA containing a 5'-triphosphorylated 
moiety. Activation of RIG-I by dsRNA ultimately induces production of type I interferon 
and activation of the transcription factor NF-B.  
Recently, it was reported that overexpression of STING (stimulator of interferon genes), a 
transmembrane protein found in the endoplasmic reticulum of numerous cells such as 
macrophages, dendritic, endothelial and epithelial cells, induces activation of NF-B and 
IRF3 to stimulate type I interferon synthesis (Ishikawa et al., 2009; Barber, 2011). STING-
knockout mice were susceptible to lethal infection after exposure to herpes simplex virus 1, 
suggesting that STING plays an important role in detecting foreign DNA.  
Another cytosolic sensor for both bacterial and viral pathogens is AIM2 (absent in melanoma 
2), which is essential for inflammasome activation in response to Fransicella tularensis, vaccinia 
virus, and mouse cytomegalovirus (Rathinam et al., 2010). AIM2 regulates caspase-1-
dependent maturation of IL-1ǃ and IL-18 and plays a role in natural killer cell-dependent 
production of interferon-, as has been shown for AIM2-deficient mice. However, the role of 
AIM2 in the pathogenesis of myocarditis has not been investigated so far. 
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PRRs Ligand Localization 
Origin of 
the ligand 
Selected references 
TLR2 Lipoprotein 
Plasma 
membrane 
Bacteria, 
viruses 
Following coronary artery ligation, tlr2-/- mice 
show reduced mortality and preserved left 
ventricular function as compared to wild-type 
mice (Shishido et al., 2003; Riad et al., 2008). 
Ischemia-reperfusion results in smaller infarct 
size (Favre et al., 2007). Tlr2-/- mice are protected 
from doxorubicin-induced cardiomyopathy 
(Nozaki et al., 2004). 
TLR3 dsRNA Endolysosome Viruses 
Tlr3-/- mice are more susceptible to EMCV 
infection and have a higher viral load, but lesser 
myocardial inflammation (Hardarson et al., 
2007).  
TLR4 
Lipopoly-
saccharide 
(LPS) 
Plasma 
membrane 
Bacteria, 
viruses 
Tlr4-/- mice are protected from ischemia-
reperfusion injury (Chong et al, 2004; Oyama et 
al., 2004; Kim et al., 2007) and LPS-induced 
mortality and cardiac dysfunction (Tavener et 
al., 2004; Nemoto et al, 2009). Tlr4-/- mice develop 
less-severe cardiac hypertrophy following 
pressure overload by aortic banding than wild-
type mice (Ha et al., 2005). 
TLR5 Flagellin 
Plasma 
membrane 
Bacteria 
Exposure to the TLR5 ligand flagellin triggers 
cardiac innate immune responses that result in 
acute contractile dysfunction (Rolli et al., 2010). 
TLR6 
Diacyl 
lipoprotein 
Plasma 
membrane 
Bacteria, 
viruses 
TLR6 Ser249Pro polymorphism has been 
associated with lower left ventricular thickness 
in hypertensive women (Sales et al., 2010). 
TLR7 
(TLR8) 
ssRNA Endolysosome
Bacteria, 
viruses 
Tlr7-/- mice show markedly reduced myocardial 
cellular infiltration in experimental autoimmune 
myocarditis (Pagni et al., 2010). TLR8 expression 
is higher in DCM patients than in controls (Satoh 
et al., 2007). 
TLR9 CpG-DNA Endolysosome
Bacteria, 
viruses 
Upon murine cytomegalovirus-induced 
myocarditis, tlr9-/- mice show higher severity of 
myocardial infiltration compared to wild-type 
(Pagni et al., 2010). Myocardial TLR9 expression 
is reduced in DCM patients (Ruppert et al., 
2008). 
RIG-I 
Short 
dsRNA 
Cytoplasm Viruses 
RIG-I mRNA is expressed at high levels in 
normal heart tissue (Ellis et al., 2002). Interferon-
 upregulates RIG-I in pericardial mesothelial 
cells, suggesting that RIG-I may be involved in 
the pathogenesis of pericarditis (Hatakeyama et 
al., 2007) 
 
Table 1. Pattern recognition receptors (PRR) and their ligands engaged in myocarditis and 
inflammatory heart disease. 
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5. Concluding remarks 
Beside direct effects of replicating viruses, unbalanced autoimmune responses associated 
with the production of auto-antibodies against cardiac tissue may also contribute to the 
progression of myocardial injury in inflammatory heart disease (Eriksson et al., 2003). The 
detection of auto-reactive antibodies directed against a number of different cardiac 
antigens is a prominent feature of all forms of persistent myocarditis and inflammatory 
cardiomyopathy, and there are reports demonstrating that the presence of anti-myosin 
autoantibodies is associated with deterioration of left ventricular function (Liu and 
Mason, 2001; Shishido et al., 2003; Dörner et al., 2005; Rose, 2009). In addition to the 
critical role of TLRs in mediating cardiac dysfunction in infectious conditions, emerging 
evidence suggests that the TLRs are also involved in modulating cardiomyocyte survival 
and ischemic myocardial injury (Chao, 2009; Riad et al., 2008). Despite significant 
progress in the identification of receptors triggering innate immune responses, further 
research is necessary to unravel the cooperative interactions between the innate and 
acquired immune system active in the protection of the heart against viral or autoimmune 
damage.  
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